3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
1
Surgery
1
Sarcoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Ductal Adenocarcinoma
1
Neoadjuvant Therapy in Elderly HER2-Positive Breast Cancer
1
Multiple Myeloma
1
Medulloblastoma
1
Lung Neoplasms
1
Liposarcoma
1
Leiomyosarcoma
1
HER2-positive Breast Cancer
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Intraductal, Noninfiltrating
1
Breast Neoplasms
1
Breast Cancer Invasive
1
Interventions
pembrolizumab
18
Specimen Handling
17
Magnetic Resonance Spectroscopy
12
Biopsy
12
Paclitaxel
9
Carboplatin
8
Radiosurgery
7
Nivolumab
7
trastuzumab deruxtecan
6
Pemetrexed
6
Leucovorin
6
Irinotecan
6
Fulvestrant
6
Fluorouracil
6
Bevacizumab
6
palbociclib
5
Oxaliplatin
5
Letrozole
5
Gemcitabine
5
Cetuximab
5
Taxes
4
Cisplatin
4
Capecitabine
4
olaparib
3
enzalutamide
3
durvalumab
3
Ipilimumab
3
Docetaxel
3
130-nm albumin-bound paclitaxel
3
sacituzumab govitecan
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
Neoadjuvant Therapy
×
30 days
×
Clear all
No trials found.